Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Yellow fever outbreak: Sanofi looks to double vaccine production

A recently opened facility will double production of Sanofi Pasteur’s vaccine Stamaril which could alleviate shortages in the wake of recent yellow fever outbreaks in parts of Africa.

Sartorius $90m IntelliCyt acquisition adds cell analysis capabilities

Sartorius has expanded its bio-analytics capabilities through the $90m (€81m) acquisition of IntelliCyt.

Corning adds Biological Industries' xeno-free stem cell medium to portfolio

Corning has struck a deal to commercialise NutriStem hPSC Medium, a xeno-free stem cell culture supplement manufactured by Biological Industries.


Pfizer and GE team on $350m modular biosimilars plant in China

Pfizer has struck a strategic partnership with GE Healthcare to construct and equip a biomanufacturing centre focused on producing biosimilars for China.

Kite opens commercial CAR T-cell plant ahead of anticipated 2017 therapy launch

Kite Pharma has opened a T-cell manufacturing facility in California it says can overcome the logistical problems of autologous therapies and treat up to 5,000 patients per year.


Porton replacing older facilities with new biopharma development plant

Porton Biopharma has begun construction on a new bioprocess development and manufacturing facility in the UK equipped with fermentation and down-stream processing suites.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...